Latest News
Managed by Maven Capital Partners (Maven) and part of the Northern Powerhouse Investment Fund, NPIF – Maven Equity Finance, has exited Intec Business Solutions (inTEC); a group offering end-to-end technology consultancy and specialist support services for SMEs.
Manchester-based inTEC has now entered into a royalty financing agreement with AIM-listed provider of royalty finance Duke Royalty, who provided GBP7.7 million to facilitate a refinancing of the Group’s debt and equity. Duke Royalty has also committed additional funding to support inTEC’s ongoing M&A strategy.
NPIF – Maven Equity Finance invested GBP750,000 into the business across two tranches in 2018 and 2019, with
Glennmont Partners from Nuveen (Glennmont), Europe’s largest pure clean energy specialist, is working with Clir Renewables (Clir), a company dedicated to maximising project returns from renewable energy assets, to identify wind turbine underperformance, to investigate solutions for improvement with project partners, and validate subsequent increases in operational output utilising its extensive domain expertise.
This relationship, which has seen Clir’s technology deployed on a number of onshore wind projects for the fund, has led Glennmont and Clir to work together with the aim of providing deep insights into wind farm performance, unearth ways to improve it, and drive forward as a
Equistone Partners Europe Limited (Equistone) has invested in adm Group (adm), an independent global marketing services business headquartered in the UK.
EIG, an institutional investor to the global energy and infrastructure sectors, is to acquire a 10 per cent interest in Australia Pacific LNG Pty Limited (APLNG) from Origin Energy Limited (Origin) for an equity purchase price of USD1.592 billion.
Enterprise Investment Scheme investment manager Deepbridge Capital has deployed over GBP50 million of capital into UK life sciences companies.
The Deepbridge Life Sciences EIS was launched in 2017 as the first life sciences focused EIS fund, providing private investors with access to a portfolio of early-stage investee companies across the biopharmaceutical, biotechnology, medical technology and digital healthcare domains.
This capital has been provided UK-wide to 87 companies across the Deepbridge Life Sciences EIS and Deepbridge Life Sciences SEIS funds, with investee companies based across England, Northern Ireland, Scotland and Wales.
Founded in 2010, Chester-based Deepbridge launched its first
Chimera Capital Ltd (Chimera Capital), an ADGM regulated fund manager and a wholly owned subsidiary of Chimera Investment has held the second close of Chimera Global Fund I LP surpassing its initial target of USD50 million.
Sixpoint Partners (Sixpoint), a global advisor serving the middle-market private equity industry, has held the closing of CREO Capital Partners V, a continuation fund for private equity sponsor CREO Capital Partners (CREO).
CREO targets investments in middle-market companies in the food sector across the branded products, private label, contract manufacturing, and logistics segments. The continuation fund enables CREO and several limited partners to extend their ownership of portfolio company Flagship Food Group (FFG), a conglomerate of leading food brands, including 505 Southwesterns, La Tortilla Factory and TJ Farms. FFG exhibited a strong trajectory beyond the traditional private equity hold period,
Click Therapeutics (Click), a specialist in Digital Therapeutics as prescription medical treatments, has closed a USD52 million upsized Series B financing. The financing round was co-led by new investors HIG BioHealth Partners (HIG BioHealth) and Accelmed Partners II (Accelmed).
Health Catalyst Capital, Revelation Partners, a top biotechnology hedge fund, and existing investors Sanofi Ventures, K2 HealthVentures, Hikma Ventures, and Ridgetop Health also particpated.
Proceeds from the Series B financing will be used to accelerate the development and commercialisation of Click’s internal prescription digital therapeutic pipeline and advance Click’s platform capabilities.
Click’s pipeline of innovative digital therapeutics spans multiple therapeutic areas,
Citcon, a mobile wallet payment provider enabling global commerce at scale, has received USD30 million in Series C financing led by Norwest Venture Partners and Cota Capital. Sierra Ventures and Sonae IM also joined the round.
The new funding will support the rapid addition of staff and global expansion that builds on the company’s international presence on four continents.
“Citcon enables global commerce at scale by allowing merchants to accept payments by mobile wallet and alternative currencies with the same ease as they process traditional credit card payments today,” says Chuck Huang, CEO and founder at Citcon. “We are honored
Blue Wolf Capital Partners (Blue Wolf), a New York-based private equity firm, is to acquire CIVCO Radiotherapy, a global leader of radiotherapy patient positioning and immobilisation equipment, from Roper Technologies.
With a nearly 40-year operating history and a track record of quality and reliability, CIVCO Radiotherapy serves a blue-chip customer base of academic and community hospitals, cancer centres and OEM manufacturers. CIVCO Radiotherapy is headquartered in Iowa and operates globally in 90-plus countries.
Jeremy Kogler, Partner at Blue Wolf Capital, says: “We are incredibly pleased to partner with CIVCO Radiotherapy’s leadership team to further strengthen the company’s longstanding leading position
Special Reports
Featured
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
